Marisa Papaluca

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This article provides an overview of the European Union (EU) framework for the marketing authorisation of medicinal products, at both European and National level, and aims to demonstrate the current position and experience with nanomedicines. It will be described how the EU promotes the development of new nanomedicines by publishing guidance, providing(More)
  • 1